Citadel Advisors »

Pelthos Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Pelthos Therapeutics (PTHS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $425k 15k 28.26

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Pelthos Therapeutics

AIGH Capital Management
Murchinson
Ikarian Capital
Boothbay Fund Management
Vanguard Capital Management
Cantor Fitzgerald, L. P.
J. Goldman & Co
Diadema Partners
Wexford Capital
Knott David M Jr
Citadel Advisors
Geode Capital Management
Pale Fire Capital SE
1492 Capital Management
Vanguard Fiduciary Trust

View all funds holding Pelthos Therapeutics